TY - JOUR
T1 - Examining the effects of HIV self-testing compared to standard HIV testing services in the general population
T2 - A systematic review and meta-analysis
AU - Jamil, Muhammad S.
AU - Eshun-Wilson, Ingrid
AU - Witzel, T. Charles
AU - Siegfried, Nandi
AU - Figueroa, Carmen
AU - Chitembo, Lastone
AU - Msimanga-Radebe, Busisiwe
AU - Pasha, Muhammad S.
AU - Hatzold, Karin
AU - Corbett, Elizabeth
AU - Barr-DiChiara, Magdalena
AU - Rodger, Alison J.
AU - Weatherburn, Peter
AU - Geng, Elvin
AU - Baggaley, Rachel
AU - Johnson, Cheryl
N1 - Funding Information:
Dr. Corbett reports grants from London School of Hygiene & Tropical Medicine, outside the submitted work. Dr. Geng reports a Viiv Healthcare research grant. Ms. Johnson reports grants from the Bill and Melinda Gates Foundation, Unitaid, and the United States Agency for International Development, during the conduct of the study; grants from the Bill and Melinda Gates Foundation, Unitaid, and the United States Agency for International Development outside the submitted work. Dr. Witzel, Dr. Rodger and Dr. Weatherburn report grants from the National Instituet of Health Research during the conduct of the study. All other authors have nothing to declare.
Funding Information:
CJ, MSJ and TCW designed the study. CF, IEW, MSJ and TCW screened abstracts and manuscripts and extracted data. IEW and EG analysed the data. All authors contributed to interpretation of results. MSJ wrote the first draft of the manuscript. All authors reviewed and commented on manuscript drafts and approved the final manuscript. This review was funded by the Bill and Melinda Gates Foundation (OPP1177903), Unitaid (PO#10140?0-600 and PO#8477?0-600) and the United States Agency for International Development (US-2015-0839 and US-2016-940). TCW, AJR, PW received grants during the conduct of the study (National Institute for Health Research Programme Grants for Applied Research Programme [PG-482 1212-20006]). EC (London School of Hygiene & Tropical Medicine), EG (ViiV Healthcare research grant) and CJ (the Bill and Melinda Gates Foundation, Unitaid, and the United States Agency for International Development) received grants outside of submitted work. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated. See supplementary material S4 for systematic review data.
Funding Information:
This review was funded by the Bill and Melinda Gates Foundation (OPP1177903), Unitaid (PO#10140–0-600 and PO#8477–0-600) and the United States Agency for International Development (US-2015-0839 and US-2016-940). TCW, AJR, PW received grants during the conduct of the study (National Institute for Health Research Programme Grants for Applied Research Programme [PG-482 1212-20006]). EC (London School of Hygiene & Tropical Medicine), EG (ViiV Healthcare research grant) and CJ (the Bill and Melinda Gates Foundation, Unitaid, and the United States Agency for International Development) received grants outside of submitted work. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.
Publisher Copyright:
© 2021 The Authors
PY - 2021/8
Y1 - 2021/8
N2 - Background: We updated a 2017 systematic review and compared the effects of HIV self-testing (HIVST) to standard HIV testing services to understand effective service delivery models among the general population. Methods: We included randomized controlled trials (RCTs) comparing testing outcomes with HIVST to standard testing in the general population and published between January 1, 2006 and June 4, 2019. Random effects meta-analysis was conducted and pooled risk ratios (RRs) were reported. The certainty of evidence was determined using the GRADE methodology. Findings: We identified 14 eligible RCTs, 13 of which were conducted in sub-Saharan Africa. Support provided to self-testers ranged from no/basic support to one-on-one in-person support. HIVST increased testing uptake overall (RR:2.09; 95% confidence interval: 1.69–2.58; p < 0.0001;13 RCTs; moderate certainty evidence) and by service delivery model including facility-based distribution, HIVST use at facilities, secondary distribution to partners, and community-based distribution. The number of persons diagnosed HIV-positive among those tested (RR:0.81, 0.45–1.47; p = 0.50; 8 RCTs; moderate certainty evidence) and number linked to HIV care/treatment among those diagnosed (RR:0.95, 0.79–1.13; p = 0.52; 6 RCTs; moderate certainty evidence) were similar between HIVST and standard testing. Reported harms/adverse events with HIVST were rare and appeared similar to standard testing (RR:2.52: 0.52–12.13; p = 0.25; 4 RCTs; very low certainty evidence). Interpretation: HIVST appears to be safe and effective among the general population in sub-Saharan Africa with a range of delivery models. It identified and linked additional people with HIV to care. These findings support the wider availability of HIVST to reach those who may not otherwise access testing.
AB - Background: We updated a 2017 systematic review and compared the effects of HIV self-testing (HIVST) to standard HIV testing services to understand effective service delivery models among the general population. Methods: We included randomized controlled trials (RCTs) comparing testing outcomes with HIVST to standard testing in the general population and published between January 1, 2006 and June 4, 2019. Random effects meta-analysis was conducted and pooled risk ratios (RRs) were reported. The certainty of evidence was determined using the GRADE methodology. Findings: We identified 14 eligible RCTs, 13 of which were conducted in sub-Saharan Africa. Support provided to self-testers ranged from no/basic support to one-on-one in-person support. HIVST increased testing uptake overall (RR:2.09; 95% confidence interval: 1.69–2.58; p < 0.0001;13 RCTs; moderate certainty evidence) and by service delivery model including facility-based distribution, HIVST use at facilities, secondary distribution to partners, and community-based distribution. The number of persons diagnosed HIV-positive among those tested (RR:0.81, 0.45–1.47; p = 0.50; 8 RCTs; moderate certainty evidence) and number linked to HIV care/treatment among those diagnosed (RR:0.95, 0.79–1.13; p = 0.52; 6 RCTs; moderate certainty evidence) were similar between HIVST and standard testing. Reported harms/adverse events with HIVST were rare and appeared similar to standard testing (RR:2.52: 0.52–12.13; p = 0.25; 4 RCTs; very low certainty evidence). Interpretation: HIVST appears to be safe and effective among the general population in sub-Saharan Africa with a range of delivery models. It identified and linked additional people with HIV to care. These findings support the wider availability of HIVST to reach those who may not otherwise access testing.
KW - HIV self-testing
KW - HIV testing services
KW - Meta-analysis
KW - Systematic Review
KW - general population
UR - http://www.scopus.com/inward/record.url?scp=85109458133&partnerID=8YFLogxK
U2 - 10.1016/j.eclinm.2021.100991
DO - 10.1016/j.eclinm.2021.100991
M3 - Article
C2 - 34278282
AN - SCOPUS:85109458133
SN - 2589-5370
VL - 38
JO - EClinicalMedicine
JF - EClinicalMedicine
M1 - 100991
ER -